|
1
|
Gyoten T, Doi T, Yamashita A, Fukahara K,
Kotoh K and Yoshimura N: Ruptured abdominal aortic aneurysm and
aortoiliac vein fistula. Asian Cardiovasc Thorac Ann. 23:449–451.
2015. View Article : Google Scholar
|
|
2
|
Knops AM, Goossens A, Ubbink DT, Balm R,
Koelemay MJ, Vahl AC, de Nie AJ, van den Akker PJ, Willems MC,
Koedam NA, et al: A decision aid regarding treatment options for
patients with an asymptomatic abdominal aortic aneurysm: A
randomised clinical trial. Eur J Vasc Endovasc Surg. 48:276–283.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bonfreschi V, Giuliani E, Malagnino FC,
Navi A, Coppi G, Silingardi R, D'Amico R and Barbieri A: Analgesia
during abdominal aortic aneurysm endovascular repair: Remifentanil
vs. fentanyl-midazolam - a randomized controlled trial. Eur J
Anaesthesiol. 26:782–787. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Candell L, Tucker LY, Goodney P, Walker J,
Okuhn S, Hill B and Chang R: Early and delayed rupture after
endovascular abdominal aortic aneurysm repair in a 10-year
multicenter registry. J Vasc Surg. 60:1146–1152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Choke E, Cockerill GW, Laing K, Dawson J,
Wilson WR, Loftus IM and Thompson MM: Whole genome-expression
profiling reveals a role for immune and inflammatory response in
abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg.
37:305–310. 2009. View Article : Google Scholar
|
|
6
|
Watanabe A, Ichiki T, Sankoda C, Takahara
Y, Ikeda J, Inoue E, Tokunou T, Kitamoto S and Sunagawa K:
Suppression of abdominal aortic aneurysm formation by inhibition of
prolyl hydroxylase domain protein through attenuation of
inflammation and extracellular matrix disruption. Clin Sci (Lond).
126:671–678. 2014. View Article : Google Scholar
|
|
7
|
Duellman T, Warren CL, Peissig P, Wynn M
and Yang J: Matrix metalloproteinase-9 genotype as a potential
genetic marker for abdominal aortic aneurysm. Circ Cardiovasc
Genet. 5:529–537. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Henriksen NA, Sorensen LT, Jorgensen LN
and Lindholt JS: Lack of association between inguinal hernia and
abdominal aortic aneurysm in a population-based male cohort. Br J
Surg. 100:1478–1482. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takahashi Y, Maki T, Liang AC, Itoh K, Lok
J, Osumi N and Arai K: p38 MAP kinase mediates transforming-growth
factor-β1-induced upregulation of matrix metalloproteinase-9 but
not -2 in human brain pericytes. Brain Res. 1593:1–8. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yurube T, Takada T, Suzuki T, Kakutani K,
Maeno K, Doita M, Kurosaka M and Nishida K: Rat tail static
compression model mimics extracellular matrix metabolic imbalances
of matrix metalloproteinases, aggrecanases, and tissue inhibitors
of metalloproteinases in intervertebral disc degeneration.
Arthritis Res Ther. 14:R512012. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brown LC, Thompson SG, Greenhalgh RM and
Powell JT: Endovascular Aneurysm Repair trial participants:
Incidence of cardiovascular events and death after open or
endovascular repair of abdominal aortic aneurysm in the randomized
EVAR trial 1. Br J Surg. 98:935–942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Walsh SR, Sadat U, Boyle JR, Tang TY,
Lapsley M, Norden AG and Gaunt ME: Remote ischemic preconditioning
for renal protection during elective open infrarenal abdominal
aortic aneurysm repair: Randomized controlled trial. Vasc
Endovascular Surg. 44:334–340. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morbelli S, Ghigliotti G, Spinella G,
Marini C, Bossert I, Cimmino M, Pane B, Rousas N, Cittadini G,
Massollo M, et al: Systemic vascular inflammation in abdominal
aortic aneurysm patients: A contrast-enhanced PET/CT study. Q J
Nucl Med Mol Imaging. 58:299–309. 2014.PubMed/NCBI
|
|
14
|
Lim TG, Kim JE, Lee SY, Park JS, Yeom MH,
Chen H, Bode AM, Dong Z and Lee KW: The daidzein metabolite,
6,7,4′-Trihydroxyisoflavone, is a novel inhibitor of PKCα in
suppressing solar UV-induced matrix metalloproteinase 1. Int J Mol
Sci. 15:21419–21432. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Choi EY, Jin JY, Lee JY, Choi JI, Choi IS
and Kim SJ: Anti-inflammatory effects and the underlying mechanisms
of action of daidzein in murine macrophages stimulated with
Prevotella intermedia lipopolysaccharide. J Periodontal Res.
47:204–211. 2012. View Article : Google Scholar
|
|
16
|
Zheng YH, Li FD, Tian C, Ren HL, Du J and
Li HH: Notch γ-secretase inhibitor dibenzazepine attenuates
angiotensin II-induced abdominal aortic aneurysm in ApoE knockout
mice by multiple mechanisms. PLoS One. 8:e833102013. View Article : Google Scholar
|
|
17
|
Soumyakrishnan S, Divya T, Kalayarasan S,
Sriram N and Sudhandiran G: Daidzein exhibits anti-fibrotic effect
by reducing the expressions of Proteinase activated receptor 2 and
TGFβ1/smad mediated inflammation and apoptosis in Bleomycin-induced
experimental pulmonary fibrosis. Biochimie. 103:23–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
King VL, Trivedi DB, Gitlin JM and Loftin
CD: Selective cyclooxygenase-2 inhibition with celecoxib decreases
angiotensin II-induced abdominal aortic aneurysm formation in mice.
Arterioscler Thromb Vasc Biol. 26:1137–1143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Iezzi R, Cotroneo AR, Filippone A, Di
Fabio F, Santoro M and Storto ML: MDCT angiography in abdominal
aortic aneurysm treated with endovascular repair: Diagnostic impact
of slice thickness on detection of endoleaks. AJR Am J Roentgenol.
189:1414–1420. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dawson JA, Choke E, Loftus IM, Cockerill
GW and Thompson MM: A randomised placebo-controlled double-blind
trial to evaluate lipid-lowering pharmacotherapy on proteolysis and
inflammation in abdominal aortic aneurysms. Eur J Vasc Endovasc
Surg. 41:28–35. 2011. View Article : Google Scholar
|
|
21
|
Peshkova IO, Schaefer G and Koltsova EK:
Atherosclerosis and Aortic Aneurysm: Is inflammation a common
denominator? FEBS J. Dec 24–2015.ePub ahead of print.
|
|
22
|
Fu XM, Yamawaki-Ogata A, Oshima H, Ueda Y,
Usui A and Narita Y: Intravenous administration of mesenchymal stem
cells prevents angiotensin II-induced aortic aneurysm formation in
apolipoprotein E-deficient mouse. J Transl Med. 11:1752013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arnaoutoglou E, Kouvelos G, Papa N,
Koulouras V, Milionis H and Matsagkas M: Regarding 'the impact of
endograft type on inflammatory response after endovascular
treatment of abdominal aortic aneurysm'. J Vasc Surg. 58:5702013.
View Article : Google Scholar
|
|
24
|
Gao F, Chambon P, Offermanns S, Tellides
G, Kong W, Zhang X and Li W: Disruption of TGF-β signaling in
smooth muscle cell prevents elastase-induced abdominal aortic
aneurysm. Biochem Biophys Res Commun. 454:137–143. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ciavarella C, Alviano F, Gallitto E, Ricci
F, Buzzi M, Velati C, Stella A, Freyrie A and Pasquinelli G: Human
Vascular Wall Mesenchymal Stromal Cells Contribute to Abdominal
Aortic Aneurysm Pathogenesis Through an Impaired Immunomodulatory
Activity and Increased Levels of Matrix Metalloproteinase-9. Circ
J. 79:1460–1469. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dilmé JF, Bellmunt S, Camacho M,
Solà-Villà D, Romero JM, Escudero JR and Vila L: Influence of
cardiovascular risk factors on levels of matrix metalloproteinases
2 and 9 in human abdominal aortic aneurysms. Eur J Vasc Endovasc
Surg. 48:374–381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pay S, Abbasov T, Erdem H, Musabak U,
Simsek I, Pekel A, Akdogan A, Sengul A and Dinc A: Serum MMP-2 and
MMP-9 in patients with Behçet's disease: Do their higher levels
correlate to vasculo-Behçet's disease associated with aneurysm
formation? Clin Exp Rheumatol. 25:S70–75. 2007.PubMed/NCBI
|
|
28
|
Khan AQ, Khan R, Rehman MU, Lateef A,
Tahir M, Ali F and Sultana S: Soy isoflavones (daidzein &
genistein) inhibit 12-O-tetradecanoylphorbol-13-acetate
(TPA)-induced cutaneous inflammation via modulation of COX-2 and
NF-κB in Swiss albino mice. Toxicology. 302:266–274. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Armstrong PJ, Franklin DP, Carey DJ and
Elmore JR: Suppression of experimental aortic aneurysms: Comparison
of inducible nitric oxide synthase and cyclooxygenase inhibitors.
Ann Vasc Surg. 19:248–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Luehmann HP, Detering L, Fors BP, Pressly
ED, Woodard PK, Randolph GJ, Gropler RJ, Hawker C and Liu Y: PET/CT
Imaging of Chemokine Receptors in Inflammatory Atherosclerosis
Using Targeted Nanoparticles. J Nucl Med. Jan 21–2016.ePub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rohm I, Atiskova Y, Drobnik S,
Fritzenwanger M, Kretzschmar D, Pistulli R, Zanow J, Krönert T,
Mall G, Figulla HR and Yilmaz A: Decreased regulatory T cells in
vulnerable atherosclerotic lesions: Imbalance between pro- and
anti-inflammatory cells in atherosclerosis. Mediators Inflamm.
2015:3647102015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eo HS, Lee KB, Kim AK, Kim MH, Kim DH and
Kim DI: Association with inflammatory cells and apolipoproteins to
the progression of atherosclerosis. J Korean Surg Soc. 80:289–296.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Khan JA, Abdul Rahman MN, Mazari FA,
Shahin Y, Smith G, Madden L, Fagan MJ, Greenman J, McCollum PT and
Chetter IC: Intraluminal thrombus has a selective influence on
matrix metalloproteinases and their inhibitors (tissue inhibitors
of matrix metalloproteinases) in the wall of abdominal aortic
aneurysms. Ann Vasc Surg. 26
|
|
34
|
Takawale A, Fan D, Basu R, Shen M,
Parajuli N, Wang W, Wang X, Oudit GY and Kassiri Z: Myocardial
recovery from ischemia-reperfusion is compromised in the absence of
tissue inhibitor of metalloproteinase 4. Circ Heart Fail.
7:652–662. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang W, Han Y, Meng G, Bai W, Xie L, Lu
H, Shao Y, Wei L, Pan S, Zhou S, et al: Direct renin inhibition
with aliskiren protects against myocardial ischemia/reperfusion
injury by activating nitric oxide synthase signaling in
spontaneously hypertensive rats. J Am Heart Assoc. 3:e0006062014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang W, Yang J, Zhang F, Guo H, Peng F and
Wang X: Activation of extracellular signal-regulated kinase 1/2 and
Sp1 may contribute to the expression of tissue inhibitor of
metal-loproteinases-1 induced by transforming growth factor-β1 in
human pulmonary arterial smooth muscle cells. Cytotherapy.
16:225–233. 2014. View Article : Google Scholar
|
|
37
|
Gao YD, Zheng JW, Li P, Cheng M and Yang
J: Store-operated Ca2+ entry is involved in transforming growth
factor-β1 facilitated proliferation of rat airway smooth muscle
cells. J Asthma. 50:439–448. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Golledge J, Clancy P, Jones GT, Cooper M,
Palmer LJ, van Rij AM and Norman PE: Possible association between
genetic polymorphisms in transforming growth factor beta receptors,
serum transforming growth factor beta1 concentration and abdominal
aortic aneurysm. Br J Surg. 96:628–632. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dai J, Losy F, Guinault AM, Pages C,
Anegon I, Desgranges P, Becquemin JP and Allaire E: Overexpression
of transforming growth factor-beta1 stabilizes already-formed
aortic aneurysms: A first approach to induction of functional
healing by endovascular gene therapy. Circulation. 112:1008–1015.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang CK, Luo J, Lai KP, Wang R, Pang H,
Chang E, Yan C, Sparks J, Lee SO, Cho J and Chang C: Androgen
receptor promotes abdominal aortic aneurysm development via
modulating inflammatory interleukin-1α and transforming growth
factor-β1 expression. Hypertension. 66:881–891. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thompson AR, Cooper JA, Jones GT, Drenos
F, van Bockxmeer FM, Biros E, Walker PJ, van Rij AM, Golledge J,
Norman PE, et al: Assessment of the association between genetic
polymorphisms in transforming growth factor beta, and its binding
protein (LTBP), and the presence, and expansion, of Abdominal
Aortic Aneurysm. Atherosclerosis. 209:367–373. 2010. View Article : Google Scholar
|
|
42
|
Yang CQ, Li W, Li SQ, Li J, Li YW, Kong
SX, Liu RM, Wang SM and Lv WM: MCP-1 stimulates MMP-9 expression
via ERK 1/2 and p38 MAPK signaling pathways in human aortic smooth
muscle cells. Cell Physiol Biochem. 34:266–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
